Biodexa Pharmaceuticals (BDRX) Enterprise Value Growth (1y) (2014 - 2025)
Biodexa Pharmaceuticals (BDRX) Enterprise Value Growth (1y) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Biodexa Pharmaceuticals | 18.43 Bn | 18.43 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -429.91% |
| Jun 30, 2025 | 15.61% |
| Dec 31, 2024 | 71.09% |
| Jun 30, 2024 | 2.45% |
| Dec 31, 2023 | -122.79% |
| Jun 30, 2023 | 19.13% |
| Dec 31, 2022 | 75.46% |
| Jun 30, 2022 | -37.65% |
| Dec 31, 2021 | -36.06% |
| Jun 30, 2021 | -9.34% |
| Dec 31, 2020 | 29.08% |
| Jun 30, 2020 | 53.46% |
| Dec 31, 2019 | -366.03% |
| Jun 30, 2019 | -105.85% |
| Dec 31, 2018 | 82.80% |
| Jun 30, 2018 | 29.03% |
| Dec 31, 2017 | 19.92% |
| Jun 30, 2017 | 23.85% |
| Dec 31, 2016 | 10.82% |
| Dec 31, 2015 | 48.91% |